World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: EUCTR
Last refreshed on: 3 April 2012
Main ID:  EUCTR2005-001618-42-IT
Date of registration: 24/10/2005
Prospective Registration: No
Primary sponsor: AMGEN
Public title: A Phase 2, Open-label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancer
Scientific title: A Phase 2, Open-label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancer
Date of first enrolment: 07/09/2005
Target sample size: 88
Recruitment status: Not Recruiting
URL:  https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-001618-42
Study type:  Interventional clinical trial of medicinal product
Study design:  Controlled: no Randomised: no Open: no Single blind: no Double blind: no Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: Placebo: Other:  
Phase: 
Countries of recruitment
Belgium Denmark Hungary Italy Sweden
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion criteria:


Age minimum:
Age maximum:
Gender:
Female: yes
Male: yes
Health Condition(s) or Problem(s) studied
Treatment of subjects with locally advanced or metastatic thyroid cancer.
MedDRA version: 6.1 Level: PT Classification code 10043744
Intervention(s)

Product Name: AMG 706
Product Code: AMG 706
Pharmaceutical Form: Film-coated tablet
Current Sponsor code: AMG 706
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number: 25-

Product Name: AMG706
Pharmaceutical Form: Film-coated tablet
Current Sponsor code: AMG706
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number: 100-

Primary Outcome(s)
Secondary Objective:
Main Objective:
Primary end point(s):
Secondary Outcome(s)
Secondary ID(s)
AMG 706 20040273
2005-001618-42-SE
Source(s) of Monetary Support
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history